Research Outputs (8)

Sort by: Date | Title

10 | 25 | 50 | 100

1/1

A D E M P All

A phase II single-arm study of LDK378 in patients with ALK-activated (ALK plus ) non-small cell lung cancer (NSCLC) previously treated with chemotherapy and crizotinib (CRZ).
Shaw AT, Mok T, Spigel DR, Nishio M, Felip E, Tan DSW, Garcia-Campelo MR, Gruen HJM, Dakhil SR, Schaefer ES, Farrell NJ, Blakesley RE, Weir A, Ristic M, Selvaggi G, Scagliotti G ( 2013 )
JOURNAL OF CLINICAL ONCOLOGY
Other conference paper
Detection of EGFR-activating mutations from plasma DNA as a potent predictor of survival outcomes in FASTACT 2: A randomized phase III study on intercalated combination of erlotinib (E) and chemotherapy (C).
Mok T, Wu YL, Lee JS, Yu CJ, Sriuranpong V, Wen W, Tsai J, Truman M, Klughammer B, Wu L ( 2013 )
JOURNAL OF CLINICAL ONCOLOGY
Other conference paper
Enhancer of Zeste Homolog 2 Silences MicroRNA-218 in Pancreatic Cancer Cells by Inducing Formation of Heterochromatin
LI Chi Han Samson, TO Ka Fai, TONG Hung Man Joanna, XIAO Zhangang, XIA, Tian, LAI Bo San Paul, CHOW Sheung Ching, ZHU Yinxin, CHAN Lam Stephen, MARQUEZ V. E., CHEN Yangchao ( 2013 )
The International Digestive Disease Forum 2013
Other conference paper
EZH2 Silences Tumor Suppressor miR-218 in Pancreatic Cancer by Inducing Heterochromatin Formation
LI Chi Han Samson, TO Ka Fai, TONG Hung Man Joanna, XIAO Zhangang, XIA, Tian, LAI Bo San Paul, CHOW Sheung Ching, ZHU Yinxin, CHAN Lam Stephen, MARQUEZ Victor E., CHEN Yangchao ( 2013 )
第三屆中港腫瘤學術論壇
Other conference paper
Manipulation and Detection of Cancer Tissues on a Microfluidic Deice
CHEONG Hio Teng, WONG Chi Hang, YUNG Pun To ( 2013 )
9th IEEE-EMBS International Summer School and Symposium on Medical Devices and Biosensors 2013
Other conference paper
Multicenter Phase II study of MK-2206 in previously treated patients (pts) with recurrent and metastatic nasopharyngeal carcinoma (NPC): Mayo Clinic Phase II Consortium (Protocol: MC1079)
Ma BB, Goh BC, Lim WT, Tan EH, Lopes GD, Hui EP, King AD, Lo KW, Loong H, Li L, Foster N, Kam M, Leung SF, Erlichman C, Chan ATC ( 2013 )
MOLECULAR CANCER THERAPEUTICS
Other conference paper
Digital Object Identifier (DOI): http://dx.doi.org/10.1158/1535-7163.TARG-13-B273
Phase III randomized, open label study (ARCHER 1050) of first-line dacomitinib (D) versus gefitinib (G) for advanced (adv) non-small cell lung cancer (NSCLC) in patients (pts) with epidermal growth factor receptor (EGFR) activating mutation(s).
Mok T, Nakagawa K, Rosell R, Wu YL, Trygstad C, Capizzi RL, Lee MY, Tsuji F, DeBenedetto R, Goldberg Z, Wang T, Liang JQ, Letrent SP, O'Connell JP, Antic V ( 2013 )
JOURNAL OF CLINICAL ONCOLOGY
Other conference paper
PREVENTION OF TAMOXIFEN-RELATED ENDOMETRIAL PATHOLOGY WITH LEVONORGESTREL INTRAUTERINE SYSTEM
Yeo W, Wong A, Chan S, Yu M, Suen J, Tam WH ( 2013 )
BREAST
Other conference paper

10 | 25 | 50 | 100

1/1

Research Outputs (8)

Share Link

Our policy towards the use of cookies